New Prostate Cancer Drug Can Extend Life Expectancy

Cabazitaxel is a new drug that has been developed to fight aggressive prostate cancer. So far, results have shown that men take the drug can extend their lives by at least two months. While this may seem a minor advancement, two months means a lot to the people suffering from the disease.

This study was conducted on men who already had aggressive cancer and have failed all other treatment options. Further studies are going to be conducted on men with less aggressive forms of this cancer. Researchers are hoping that men who take this drug at an earlier stage will have a much longer life expectancy.

Cabazitaxel is a derivative of the currently used drug Taxotere. Taxotere is used as a last resort to treat aggressive prostate cancer. The draw back of this drug is that the body processes it too quickly, and the patient does not receive the full effect of treatment. Cabazitaxel is a modification of this drug that stays in the system much longer providing the patient extended treatment.

Further testing will be done to see if the same results are achieved. Once testing is completed the drug manufacturer will apply to the FDA for release of the medication.